• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fulgent Genetics Inc (NQ: FLGT )

    22.81 -0.06 (-0.26%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 751
    Open 22.81
    Bid (Size) 22.70 (1)
    Ask (Size) 23.20 (2)
    Prev. Close 22.87
    Today's Range 22.81 - 22.81
    52wk Range 18.91 - 34.36
    Shares Outstanding 29,926,846
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Fulgent Reports Second Quarter 2024 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
    From Fulgent Genetics, Inc.
    Via Business Wire

    Performance

    YTD
    -22.12%
    -22.12%
    1 Month
    -0.70%
    -0.70%
    3 Month
    +5.50%
    +5.50%
    6 Month
    -10.48%
    -10.48%
    1 Year
    -32.11%
    -32.11%

    More News

    Read More
    Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
    From Fulgent Pharma
    Via Business Wire
    Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
    From Fulgent Pharma
    Via Business Wire
    Earnings Preview: Fulgent Genetics
    Via Benzinga
    Why Is Fulgent Genetics Stock Moving Higher Today?
    Via Benzinga
    Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
    From Fulgent Pharma
    Via Business Wire
    FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Fulgent Reports First Quarter 2024 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
    From Fulgent Genetics, Inc.
    Via Business Wire
    Earnings Outlook For Fulgent Genetics
    Via Benzinga
    Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
    From Fulgent Genetics, Inc.
    Via Business Wire
    The 3 Best Digital Health Stocks for Personalized Medicine
    Via InvestorPlace
    Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
    From Fulgent Genetics, Inc.
    Via Business Wire
    Earnings Scheduled For November 3, 2023
    Via Benzinga
    Fulgent Reports Third Quarter 2023 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
    From Fulgent Genetics, Inc.
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Fulgent Reports Second Quarter 2023 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Earnings Scheduled For August 4, 2023
    Via Benzinga
    Exagen Inc. Appoints Paul Kim to Board of Directors
    From Exagen Inc.
    Via GlobeNewswire
    Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
    From Fulgent Genetics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.